Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Thomas Kitzing

2PUBLICATIONS

19CO-AUTHORS

Tumour immunologyMolecular medicine

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Feb 10, 2025

TIGIT inhibitor M6223 as monotherapy or in combination with bintrafusp alfa in patients with advanced solid tumors: a first-in-human, phase 1, dose-escalation trial.

Aung Naing, Meredith McKean, Anthony Tolcher

|Aug 20, 2024

Dual A2A/A2B Adenosine Receptor Antagonist M1069 Counteracts Immunosuppressive Mechanisms of Adenosine and Reduces Tumor Growth In Vivo.

Kai Schiemann, Natalya Belousova, Armine Matevossian

Pageof 1

Frequent Collaborators

1 joint publications

Kai Schiemann

1 joint publications

Natalya Belousova

1 joint publications

Armine Matevossian

1 joint publications

Kalyan C Nallaparaju

1 joint publications

Giorgio Kradjian

1 joint publications

Meghana Pandya

1 joint publications

Zhouxiang Chen

1 joint publications

Esengul Aral

1 joint publications

Eva-Maria Krauel

1 joint publications

Elissaveta Petrova

Frequent Collaborators

1 joint publications

Kai Schiemann

1 joint publications

Natalya Belousova

1 joint publications

Armine Matevossian

1 joint publications

Kalyan C Nallaparaju

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on : Aug 23, 2019

See more related videos

Top Related Videos

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

Published on : Oct 27, 2014

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on : Aug 23, 2019

See more related videos